41352 Korschenbroich / Liedberg, de
+49 (2161) 356126
OQEMA have entered into a new partnership with CHEMADA Industries Ltd.
The OQEMA Group will act as a European agent and distributor for the full range of CHEMADA’s high-quality brominated intermediates and brominating reagents, and also provide custom manufacturing based on other technologies to the Benelux countries, France, Germany, Denmark, Switzerland, the UK, the Czech Republic, Slovenia, the Baltic countries, Italy and Hungary.
Dr James Berwick, Group Director of Speciality Chemicals, OQEMA AG, comments, ‘As a leading distributor of speciality products in 21 European countries, the intermediate business of CHEMADA represents a strong addition to our portfolio. As the OQEMA Group continues to build a wider chemical intermediate range, we are increasingly focused on bringing the leaders and innovators with a strong brand and market reputation into key areas of our portfolio. We are therefore very proud to be the exclusive distribution partner for the intermediate product range in major European countries, and our technical sales expert teams are ready to offer the CHEMADA range to our network.’
Both the OQEMA Group and CHEMADA share the common values of reliability, simplicity and agility. Both companies place significant emphasis on putting the customer first by empowering their workforce and supporting the enthusiastic spirit of their people. CHEMADA is especially keen on the OQEMA Group’s market presence and the expertise of their teams.
Eyal Azulay, CEO of CHEMADA Industries Ltd., comments, ‘We look forward to this new agency and distribution partnership with the OQEMA Group. OQEMA’s strong market and application experience, i.e. in the life-science and technical industries, and its proven performance as a value creator in the distribution markets, combined with its willingness and capability to represent the complete CHEMADA product range, are a good guarantee for a successful collaboration.’
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.